These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4073092)

  • 1. In vitro activity and disk susceptibility of Timentin: current status.
    Fuchs PC; Barry AL; Jones RN
    Am J Med; 1985 Nov; 79(5B):25-32. PubMed ID: 4073092
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of timentin.
    Thomas MG; Lang SD
    N Z Med J; 1985 May; 98(779):403-4. PubMed ID: 3857527
    [No Abstract]   [Full Text] [Related]  

  • 3. Sensitivity of clinical bacterial isolates to Timentin (ticarcillin/clavulanic acid).
    Villiger JW
    N Z Med J; 1986 Nov; 99(814):914. PubMed ID: 3492692
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro susceptibility of piperacillin v timentin and ticarcillin.
    Bremner DA
    N Z Med J; 1987 May; 100(823):299-300. PubMed ID: 3138579
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro susceptibility-resistance patterns of bacterial isolates from burn patients to augmentin and timentin.
    Holder IA; Vanderpool L; Wesselman J
    J Burn Care Rehabil; 1985; 6(4):331-4. PubMed ID: 3879938
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative disk and broth dilution susceptibility test results with ticarcillin and timentin against Pseudomonas aeruginosa and Pseudomonas maltophilia.
    Traub WH; Spohr M
    Chemotherapy; 1987; 33(5):340-6. PubMed ID: 3117502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of ticarcillin plus clavulanic acid (BRL 28500, 'Timentin') against ticarcillin-resistant gram-negative rods.
    Chattopadhyay B; Hall I
    Curr Med Res Opin; 1984; 9(3):157-60. PubMed ID: 6568146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of agar dilution, identification of beta-lactamases and disc diffusion methods for assessing the sensitivity to ticarcillin-clavulanic acid.
    Joly B; Chanal M; Sirot D; Cluzel M; Sirot J; Cluzel R
    J Antimicrob Chemother; 1986 May; 17 Suppl C():27-33. PubMed ID: 3522530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid.
    Fuchs PC; Jones RN; Barry AL; Thornsberry C
    J Clin Microbiol; 1984 Apr; 19(4):555-7. PubMed ID: 6715524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates.
    Fuchs PC; Barry AL; Thornsberry C; Jones RN
    Antimicrob Agents Chemother; 1984 Mar; 25(3):392-4. PubMed ID: 6721472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centers.
    Barry AL; Ayers LW; Gavan TL; Gerlach EH; Jones RN
    Eur J Clin Microbiol; 1984 Jun; 3(3):203-6. PubMed ID: 6147246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timentin resistance.
    Masterton RG; Garner PJ; Harrison NA; Rainford DJ
    Lancet; 1987 Oct; 2(8565):975-6. PubMed ID: 2889900
    [No Abstract]   [Full Text] [Related]  

  • 13. Susceptibility testing recommendations for ticarcillin/clavulanic acid in the Stokes' disc diffusion test.
    Sutherland R
    J Antimicrob Chemother; 1989 Sep; 24(3):463-4. PubMed ID: 2808198
    [No Abstract]   [Full Text] [Related]  

  • 14. Clavulanic acid/antibiotic ratios.
    Rolinson GN
    J Antimicrob Chemother; 1985 Feb; 15(2):256-7. PubMed ID: 3980316
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of timentin in intensive care].
    Gérard A; Dureux JB; Canton P; May T; Schmit JL
    Pathol Biol (Paris); 1986 May; 34(5):448-50. PubMed ID: 3534719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activities in vitro of timentin (ticarcillin/clavulanic acid) and ureidopenicillins against ampicillin-resistant clinical isolates.
    Griffin KE; Slocombe B
    J Chemother; 1989 Jul; 1(4 Suppl):267-9. PubMed ID: 16312396
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of parenteral ticarcillin formulated with clavulanic acid: Timentin.
    Staniforth DH; Coates PE; Davies BE; Horton R
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):123-9. PubMed ID: 3699938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of a ticarcillin-clavulanic acid (timentin) combination on bacteria resistant to ticarcillin].
    Rouhan D; Le Noc P; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):461-5. PubMed ID: 3937121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter study.
    Fuchs PC; Jones RN; Barry AL; Allen SD; Aldridge KE; Gerlach EH; Sommers HM
    Diagn Microbiol Infect Dis; 1988 Jan; 9(1):47-50. PubMed ID: 3370931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro activity of the combination ticarcillin-clavulanic acid on bacterial isolates in surgery].
    Branger C; Kitzis M; Le Mée J
    Pathol Biol (Paris); 1986 Apr; 34(4):245-8. PubMed ID: 3528998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.